DrugsControl Media Services

News Detail

Low levels of UGT2B17 enzyme the cause of heart damage tied to Diclofenac use (28-04-2023)

Washington, 27 April 2023: According to recent research, the safety issues surrounding the commonly used pain reliever, diclofenac, may be linked to a poorly understood drug-metabolizing enzyme. The expression of this enzyme can vary as much as 3,000 times from one individual to ......
View Details

Source : SciTechDaily
diclofenac drug-metabolizing enzyme Clinical Pharmacology & Therapeutics UGT2B17 Bhagwat Prasad drugscontrol

Related News